NO980881L - Fremgangsmater og blandinger for selektiv modifikasjon av nukleinsyrer - Google Patents
Fremgangsmater og blandinger for selektiv modifikasjon av nukleinsyrerInfo
- Publication number
- NO980881L NO980881L NO19980881A NO980881A NO980881L NO 980881 L NO980881 L NO 980881L NO 19980881 A NO19980881 A NO 19980881A NO 980881 A NO980881 A NO 980881A NO 980881 L NO980881 L NO 980881L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- methods
- nucleic acids
- selective modification
- inactivating
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000012986 modification Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 229920001222 biopolymer Polymers 0.000 abstract 2
- 230000000415 inactivating effect Effects 0.000 abstract 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000013638 trimer Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
- C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/06—Inactivation or attenuation by chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10161—Methods of inactivation or attenuation
- C12N2730/10163—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16061—Methods of inactivation or attenuation
- C12N2740/16063—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32461—Methods of inactivation or attenuation
- C12N2770/32463—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/18011—Details ssRNA Bacteriophages positive-sense
- C12N2795/18111—Leviviridae
- C12N2795/18161—Methods of inactivation or attenuation
- C12N2795/18163—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
Det beskrives anordninger og fremgangsmåter for inaktivering av virus og andre organismer i celle-holdige eller biopolymer-holdige blandinger uten vesentlig endring av proteiner eller andre biopolymerer, ved å bringe slike blandinger i kontakt med selektivt inaktiverende etyleniminoligomer-midler, så som trimeren eller tetrameren.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/521,245 US6114108A (en) | 1995-08-29 | 1995-08-29 | Methods and compositions for the selective modification of viral nucleic acids |
PCT/US1996/014040 WO1997007674A1 (en) | 1995-08-29 | 1996-08-29 | Methods and compositions for the selective modification of nucleic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
NO980881D0 NO980881D0 (no) | 1998-02-27 |
NO980881L true NO980881L (no) | 1998-04-27 |
Family
ID=24075988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19980881A NO980881L (no) | 1995-08-29 | 1998-02-27 | Fremgangsmater og blandinger for selektiv modifikasjon av nukleinsyrer |
Country Status (18)
Country | Link |
---|---|
US (1) | US6114108A (no) |
EP (2) | EP0915648B1 (no) |
JP (2) | JP2001520635A (no) |
KR (1) | KR100486765B1 (no) |
AT (2) | ATE217144T1 (no) |
AU (1) | AU694892B2 (no) |
BR (1) | BR9610306A (no) |
CA (1) | CA2230671A1 (no) |
DE (2) | DE69621161T2 (no) |
DK (1) | DK0915648T3 (no) |
ES (1) | ES2173314T3 (no) |
HK (1) | HK1042254A1 (no) |
IL (1) | IL123467A0 (no) |
NO (1) | NO980881L (no) |
NZ (1) | NZ316787A (no) |
PL (1) | PL187759B1 (no) |
PT (1) | PT915648E (no) |
WO (1) | WO1997007674A1 (no) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5691132A (en) | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
US6177441B1 (en) | 1995-06-05 | 2001-01-23 | Cerus Corporation | Treating red blood cell solutions with anti-viral agents |
US6136586A (en) * | 1995-08-29 | 2000-10-24 | Vi Technologies, Inc. | Methods for the selective modification of viral nucleic acids |
US20040053208A1 (en) * | 1995-08-29 | 2004-03-18 | V. I. TECHNOLOGIES, Inc. | Methods to selectively inactivate parasites in biological compositions |
US20040048235A1 (en) * | 1995-08-29 | 2004-03-11 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
DE19633684A1 (de) * | 1996-08-12 | 1998-02-19 | Dirk Dipl Ing Vollenbroich | Verfahren zur Inaktivierung von lipidumhüllten Viren |
US6093725A (en) * | 1997-01-06 | 2000-07-25 | Cerus Corporation | Frangible compounds for pathogen inactivation |
US6514987B1 (en) | 1997-01-06 | 2003-02-04 | Cerus Corporation | Frangible compounds for pathogen inactivation |
US5891705A (en) * | 1997-04-08 | 1999-04-06 | Pentose Pharmaceuticals, Inc. | Method for inactivating a virus |
US6093564A (en) | 1997-10-03 | 2000-07-25 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
US6352695B1 (en) * | 1997-10-03 | 2002-03-05 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
EP1045704B1 (en) | 1998-01-06 | 2004-09-22 | Cerus Corporation | Methods for quenching pathogen inactivators in biological materials |
US6369048B1 (en) * | 1998-01-12 | 2002-04-09 | V.I. Technologies, Inc. | Methods and compositions for inactivating viruses |
CA2332314A1 (en) | 1998-06-11 | 1999-12-16 | Cerus Corporation | Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells |
DE19827750C1 (de) * | 1998-06-22 | 1999-07-29 | Centeon Pharma Gmbh | Verfahren zum Abtrennen von HIV aus einer Flüssigkeit |
US6099734A (en) * | 1998-07-08 | 2000-08-08 | Baxter International Inc. | Apparatus, membranes and methods for removing organic compounds from a biological fluid |
US6908553B1 (en) | 1998-07-08 | 2005-06-21 | Baxter International Inc. | Composite membrane with particulate matter substantially immobilized therein |
DE19836559A1 (de) | 1998-08-12 | 2000-03-23 | Antigen Gmbh | Gefäß zur Entnahme von Blut |
US6403359B1 (en) | 1998-09-25 | 2002-06-11 | V. I. TECHNOLOGIES, Inc. | Solid phase quenching systems |
US6617100B2 (en) | 1998-09-25 | 2003-09-09 | V.I. Technologies, Inc. | Solid phase quenching systems |
EP1115889A4 (en) * | 1998-09-25 | 2003-02-05 | Vi Technologies Inc | SELECTIVE PROCESS FOR INACTIVATION OF VIRUSES IN BIOLOGICAL COMPOSITIONS |
US6150109A (en) | 1999-01-25 | 2000-11-21 | V. I. TECHNOLOGIES, Inc. | Lipophilic quenching of viral inactivating agents |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
WO2002055095A2 (en) * | 2000-11-06 | 2002-07-18 | Vi Technologies Inc | Use of aziridino-compounds in the treatment of immune dysfunctions |
US6602718B1 (en) * | 2000-11-08 | 2003-08-05 | Becton, Dickinson And Company | Method and device for collecting and stabilizing a biological sample |
US20020131958A1 (en) * | 2001-01-22 | 2002-09-19 | John Chapman | Method for purifying a biological composition |
US6635679B2 (en) * | 2001-05-14 | 2003-10-21 | Akzo Nobel N.V. | Methods and compositions for inactivating viruses |
WO2002092806A1 (en) * | 2001-05-15 | 2002-11-21 | V.I. Technologies, Inc. | Apparatus for the inactivation of pathogens in protein-containingfluids |
CA2466251A1 (en) * | 2001-11-06 | 2003-08-14 | V.I. Technologies, Inc. | Therapeutic use of aziridino compounds |
EP2589371B1 (en) | 2001-12-28 | 2015-03-25 | Terumo Kabushiki Kaisha | Blood bag system and method of inactivating pathogenic microorganisms |
US20050074743A1 (en) * | 2003-10-06 | 2005-04-07 | Purmal Andrei A. | Method and composition for treating a biological sample |
CN103961731B (zh) | 2004-10-29 | 2017-01-18 | 塞鲁斯公司 | 用于红细胞灭活过程的改进的猝灭方法 |
BRPI0911176B8 (pt) | 2008-04-09 | 2021-05-25 | Cerus Corp | método de tratar uma composição de célula vermelha sanguínea, composição de célula vermelha sanguínea, e método de reduzir a desidratação em uma composição de célula vermelha sanguínea |
DK2855513T3 (en) | 2012-06-01 | 2017-03-13 | Boehringer Ingelheim Vetmedica Gmbh | SCHMALLENBERGVIRUS (SBV) VACCINE, PROCEDURES FOR MANUFACTURING AND USING THEREOF |
CA3003477A1 (en) | 2015-11-01 | 2017-05-04 | Glycobac, Llc | Virus-free cell lines and methods for obtaining same |
AU2017261705B2 (en) * | 2016-05-10 | 2024-04-18 | Najit Technologies, Inc. | Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production |
KR102198877B1 (ko) | 2019-07-16 | 2021-01-05 | 정소영 | 블루 라이트 차단 필터 |
CN113322252A (zh) * | 2020-12-28 | 2021-08-31 | 广州凯普医药科技有限公司 | 一种拭子样本保存液 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3492289A (en) * | 1966-06-13 | 1970-01-27 | Dow Chemical Co | Polymers of alkylenimines |
US4058599A (en) * | 1973-02-24 | 1977-11-15 | Bayer Aktiengesellschaft | Ethyleneimine inactivated organisms |
US4036952A (en) * | 1973-02-24 | 1977-07-19 | Bayer Aktiengesellschaft | Ethyleneimine inactivated microorganisms |
RU594771C (ru) * | 1973-05-07 | 1993-07-07 | Всесоюзный научно-исследовательский ящурный институт | Средство дл инактивации вирусов при изготовлении противовирусных препаратов |
US4841023A (en) * | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
US5000951A (en) * | 1987-03-09 | 1991-03-19 | Diamond Scientific Company | Multivalent canine distemper virus vaccine |
US5055485A (en) * | 1988-12-02 | 1991-10-08 | New York Blood Center, Inc. | Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides |
RU1768636C (ru) * | 1989-08-16 | 1992-10-15 | Всесоюзный научно-исследовательский ветеринарный институт птицеводства | Способ получени антигена вируса болезни Гамборо |
US5232844A (en) * | 1990-05-15 | 1993-08-03 | New York Blood Center | Photodynamic inactivation of viruses in cell-containing compositions |
US5120649A (en) * | 1990-05-15 | 1992-06-09 | New York Blood Center, Inc. | Photodynamic inactivation of viruses in blood cell-containing compositions |
US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
EP0500893A4 (en) * | 1990-09-04 | 1993-03-10 | Edward Shanbrom | Preservation of blood, tissues and biological fluids |
GB9108682D0 (en) * | 1991-04-23 | 1991-06-12 | Wellcome Found | Production of vaccines |
FR2679253B1 (fr) * | 1991-07-15 | 1994-09-02 | Pasteur Institut | Proteines de resistance a la cycloheximide. utilisation comme marqueur de selection par exemple pour controler le transfert d'acides nucleiques. |
EP0612532A3 (en) * | 1993-02-26 | 1998-02-04 | Solvay Animal Health, Inc. | Canine coronavirus vaccine from feline enteric coronavirus |
EP0773716A4 (en) * | 1995-06-07 | 1999-08-04 | Cerus Corp | TREATMENT OF RED BLOOD CELL SOLUTIONS WITH ANTIVRAL ACTIVE SUBSTANCES |
-
1995
- 1995-08-29 US US08/521,245 patent/US6114108A/en not_active Expired - Fee Related
-
1996
- 1996-08-29 IL IL12346796A patent/IL123467A0/xx not_active IP Right Cessation
- 1996-08-29 DE DE69621161T patent/DE69621161T2/de not_active Expired - Fee Related
- 1996-08-29 PL PL96325338A patent/PL187759B1/pl not_active IP Right Cessation
- 1996-08-29 JP JP51061997A patent/JP2001520635A/ja not_active Ceased
- 1996-08-29 DK DK96929846T patent/DK0915648T3/da active
- 1996-08-29 EP EP19960929846 patent/EP0915648B1/en not_active Expired - Lifetime
- 1996-08-29 PT PT96929846T patent/PT915648E/pt unknown
- 1996-08-29 AU AU69099/96A patent/AU694892B2/en not_active Ceased
- 1996-08-29 ES ES96929846T patent/ES2173314T3/es not_active Expired - Lifetime
- 1996-08-29 NZ NZ31678796A patent/NZ316787A/xx unknown
- 1996-08-29 AT AT96929846T patent/ATE217144T1/de not_active IP Right Cessation
- 1996-08-29 EP EP20010107780 patent/EP1129728B1/en not_active Expired - Lifetime
- 1996-08-29 DE DE1996635871 patent/DE69635871T2/de not_active Expired - Fee Related
- 1996-08-29 AT AT01107780T patent/ATE319483T1/de not_active IP Right Cessation
- 1996-08-29 KR KR10-1998-0701540A patent/KR100486765B1/ko not_active IP Right Cessation
- 1996-08-29 BR BR9610306A patent/BR9610306A/pt not_active Application Discontinuation
- 1996-08-29 WO PCT/US1996/014040 patent/WO1997007674A1/en active IP Right Grant
- 1996-08-29 CA CA 2230671 patent/CA2230671A1/en not_active Abandoned
-
1998
- 1998-02-27 NO NO19980881A patent/NO980881L/no not_active Application Discontinuation
-
2002
- 2002-03-04 HK HK02101644.6A patent/HK1042254A1/zh unknown
- 2002-09-04 JP JP2002259404A patent/JP2003176238A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK0915648T3 (da) | 2002-08-26 |
DE69621161D1 (de) | 2002-06-13 |
NZ316787A (en) | 1999-11-29 |
EP1129728A1 (en) | 2001-09-05 |
EP1129728B1 (en) | 2006-03-08 |
AU694892B2 (en) | 1998-07-30 |
CA2230671A1 (en) | 1997-03-06 |
KR19990044303A (ko) | 1999-06-25 |
HK1042254A1 (zh) | 2002-08-09 |
DE69635871T2 (de) | 2007-05-24 |
KR100486765B1 (ko) | 2005-09-02 |
BR9610306A (pt) | 1999-07-06 |
AU6909996A (en) | 1997-03-19 |
EP0915648B1 (en) | 2002-05-08 |
EP0915648A1 (en) | 1999-05-19 |
ES2173314T3 (es) | 2002-10-16 |
PL325338A1 (en) | 1998-07-20 |
PT915648E (pt) | 2002-09-30 |
EP0915648A4 (no) | 1999-05-19 |
PL187759B1 (pl) | 2004-10-29 |
ATE217144T1 (de) | 2002-05-15 |
NO980881D0 (no) | 1998-02-27 |
WO1997007674A1 (en) | 1997-03-06 |
DE69621161T2 (de) | 2002-11-21 |
JP2003176238A (ja) | 2003-06-24 |
IL123467A0 (en) | 1998-09-24 |
JP2001520635A (ja) | 2001-10-30 |
US6114108A (en) | 2000-09-05 |
ATE319483T1 (de) | 2006-03-15 |
DE69635871D1 (de) | 2006-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO980881L (no) | Fremgangsmater og blandinger for selektiv modifikasjon av nukleinsyrer | |
ES2563677T3 (es) | Composiciones de combinaciones de Neisseria | |
BR9808154A (pt) | Moléculas de ácido nucléico codificando enzimas tendo atividade de frutosil polimerase | |
BR9813968A (pt) | Moléculas de ácido nucléico que codificam proteìnas tendo atividade frutosil transferase e processos para produzir inulina de cadeia longa | |
BR9911396A (pt) | Estabilização de enzima por meio de tensoativos catiÈnicos | |
HUP0301659A2 (hu) | Kukorica cellulóz-szintetázok és alkalmazásuk | |
CA2232604A1 (fr) | Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament | |
CA2250078A1 (en) | Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process | |
DE60236864D1 (de) | Chimere alphavirus-replikon-partikel | |
WO2001026682A3 (en) | Modified plant viruses and methods of use thereof | |
NO20004161L (no) | Gruppe B streptokoccus antigener | |
NO952039L (no) | Proteiner med glykosyltransferase-aktivitet | |
DE60024100D1 (de) | Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen | |
NO910982L (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
ATE414146T1 (de) | Methoden zur herstellung von helpervirusfreien präparationen von freien rekombinenten aav- vektoren mit hohem titer | |
NO983946D0 (no) | Parapoksyviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner | |
ES2187504T3 (es) | Vectores no oncovirales, basados en el vmmp, con encapsidacion defectuosa. | |
EP2336339A3 (en) | Production of viral vectors | |
DE60107718D1 (de) | Konservierung von zellen | |
DK0852623T3 (da) | Nukleinsyremolekyler kodende for proteiner, som medierer adhæsionen af Neisseria-celler til humane celler | |
DE60334008D1 (de) | Reduzierter slam abhängiger zell eintritt | |
DE60042922D1 (de) | Virale expressionsvektoren für pflanzen | |
HUP0104254A2 (hu) | Ezrin szabályozó/kihajtogató peptidek | |
DK0952982T3 (da) | Hidtil ukendte hepatitis B inhibitorer | |
ATE263234T1 (de) | Veränderte, kleine rna-viren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
FC2A | Withdrawal, rejection or dismissal of laid open patent application |